CTLA4 and neoplasm: Consistent with a previous finding that tumor-draining lymphatics are indispensable for checkpoint therapy,29,40 we found that CLN-mediated immune activation was essential for anti-PD-1/CTLA-4 efficacy (Supplementary information, Fig. S9a, b).